-
Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood.
Nicolaides KH, Syngelaki A, Del Mar Gil M, Soledad Quezada M, Zinevich Y.
Fetal Diagn Ther 2014;35:212-7. pdf -
Contribution of Method of Conception on Pregnancy Outcome after the 11-13 Weeks Scan.
Chaveeva P, Carbone IF, Syngelaki A, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:9-22. -
Assisted conception and placental perfusion assessed by uterine artery Doppler at 11-13 weeks' gestation.
Carbone IF, Cruz JJ, Sarquis R, Akolekar R, Nicolaides KH.
Hum Reprod 2011;26:1659-64. -
Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH.
Prenat Diagn 2000;20:495-9. -
Early prenatal diagnosis of triploidy.
Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH.
Am J Obstet Gynecol 1997;176:550-4. -
Prenatal diagnosis of triploidy during the second trimester of pregnancy.
Jauniaux E, Brown R, Rodeck C, Nicolaides KH.
Obstet Gynecol 1996;88:983-9. -
Superovulation, IGFBP-1 and birth weight.
Johnson MR, Irvine R, Hills F, Bolton VN, Abbas AA, Brooks AA, Allman AC, Chard T, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:193-5.